Intervention not reported
Serious adverse events · people with cancer pain
1 finding from 1 review
Intervention not reported
Serious adverse events · adults with chronic musculoskeletal pain (osteoarthritis)
1 finding from 1 review
no estimate extracted
30 participants
Very low
Number withdrawn due to adverse events · patients with osteoarthritis
Celecoxib showed no clear difference in number withdrawn due to adverse events compared with tNSAIDs (low certainty).
1 finding from 1 review
Intervention not reported
Systemic adverse events · adults with chronic musculoskeletal pain (osteoarthritis)
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Number of participants reporting an adverse event · patients with hip osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Number of participants experiencing any serious adverse events · patients with osteoarthritis
It is very uncertain whether celecoxib changes number experiencing any serious adverse events compared with tNSAIDs (very low certainty).
1 finding from 1 review
Number of participants reporting an adverse event · acute gout
Low‐dose colchicine showed no clear difference in total number of participants reporting adverse events compared with NSAIDs (low certainty).
1 finding from 1 review
Proportion of participants experiencing adverse events · Patients with acute low‐back pain
It is very uncertain whether selective COX‐2 inhibitors changes proportion of participants experiencing adverse events compared with non‐selective NSAIDs (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · patients with osteoarthritis
Tramadol alone may leads to higher number of participants who withdrew due to adverse events compared with NSAIDs (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · patients with osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
Number of participants experiencing any serious adverse events · patients with osteoarthritis
It is very uncertain whether tramadol alone changes number of participants experiencing any serious adverse events compared with NSAIDs (very low certainty).
1 finding from 1 review
Number of participants experiencing any serious adverse events · patients with osteoarthritis
1 finding from 1 review
Adverse eventsPercentage of participants with any adverse event · patients undergoing knee arthroscopy
Morphine showed no clear difference in adverse eventsPercentage of participants with any adverse event compared with NSAIDs (moderate certainty).
1 finding from 1 review
Withdrawals due to adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
Withdrawals due to adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
Withdrawals due to adverse events · children and adolescents with chronic non‐cancer pain
1 finding from 1 review
Intervention not reported
Topical ketoprofen gel Local adverse events · adults with chronic musculoskeletal pain (osteoarthritis)
1 finding from 1 review
Intervention not reported
Topical diclofenac gel or solution Local adverse events · adults with chronic musculoskeletal pain (osteoarthritis)
1 finding from 1 review
Intervention not reported
Adverse events (Re‐operation for bleeding (reoperation for major bleeding within 30 days (yes/no))) · adults undergoing surgery
It is very uncertain whether the intervention changes adverse events (Re‐operation for bleeding (reoperation for major… (very low certainty).
1 finding from 1 review